Esther Simon-Fernandez

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Correction: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Journal: Cell death & disease

Published: May 18, 2026

Correction: Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Correction: Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Journal: Cell death & disease

Published: April 17, 2026

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Journal: Cell death & disease

Published: June 23, 2025

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Journal: Cell death & disease

Published: June 23, 2025

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Journal: Cell death & disease

Published: April 01, 2025

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Journal: Cell death & disease

Published: April 01, 2025

Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy.

Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy.

Journal: Frontiers in cell and developmental biology

Published: October 03, 2024

Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy.

Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy.

Journal: Frontiers in cell and developmental biology

Published: March 11, 2024

Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression.

Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression.

Journal: Brain : a journal of neurology

Published: February 27, 2024

Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration.

Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration.

Journal: Scientific reports

Published: April 21, 2023

Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations.

Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations.

Journal: Cell death & disease

Published: March 22, 2023

Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy.

Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy.

Journal: Neuromuscular disorders : NMD

Published: October 24, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026